{
  "created_at": "Fri Feb 12 23:37:32 +0000 2021",
  "id_str": "1360363819881680899",
  "full_text": "At least in theory, vaccine makers should be able to produce 2.1 shots—more than a full regimen—for each of the world’s 5.8bn adults by the end of the year https://t.co/68b8SSy1TN",
  "display_text_range": [
    0,
    179
  ],
  "entities": {
    "hashtags": [],
    "symbols": [],
    "user_mentions": [],
    "urls": [
      {
        "url": "https://t.co/68b8SSy1TN",
        "expanded_url": "https://econ.st/2NkOBgy",
        "display_url": "econ.st/2NkOBgy",
        "indices": [
          156,
          179
        ]
      }
    ]
  },
  "user": {
    "name": "The Economist",
    "screen_name": "TheEconomist",
    "profile_image_url_https": "https://pbs.twimg.com/profile_images/879361767914262528/HdRauDM-_normal.jpg"
  },
  "retweet_count": 35,
  "favorite_count": 85,
  "possibly_sensitive": false,
  "original_created_at": "Fri Feb 12 23:03:03 +0000 2021",
  "localize": [
    {
      "locale": "zh",
      "full_text": "至少从理论上讲，到今年年底，疫苗制造商应该能够为世界上58亿成年人每人生产2.1支疫苗--超过一个完整的疗程https://t.co/68b8SSy1TN。"
    },
    {
      "locale": "zh-Hant",
      "full_text": "至少從理論上講，到今年年底，疫苗製造商應該能夠爲世界上58億成年人每人生產2.1支疫苗--超過一個完整的療程https://t.co/68b8SSy1TN。"
    }
  ]
}